midazolam and lcl161

midazolam has been researched along with lcl161 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cameron, S; Dhuria, S; Einolf, H; Gu, H; Mangold, J; Sen, S; Wang, L	1

Other Studies

1 other study(ies) available for midazolam and lcl161

Article	Year
Time-dependent inhibition and induction of human cytochrome P4503A4/5 by an oral IAP antagonist, LCL161, in vitro and in vivo in healthy subjects. Journal of clinical pharmacology, 2013, Volume: 53, Issue:6 Topics: Adult; Area Under Curve; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Female; Hepatocytes; Humans; Inhibitor of Apoptosis Proteins; Male; Microsomes, Liver; Midazolam; Middle Aged; Models, Biological; Pregnane X Receptor; Receptors, Steroid; RNA, Messenger; Thiazoles; Time Factors; Young Adult	2013

Article

Year

Time-dependent inhibition and induction of human cytochrome P4503A4/5 by an oral IAP antagonist, LCL161, in vitro and in vivo in healthy subjects.

Journal of clinical pharmacology, 2013, Volume: 53, Issue:6

Topics: Adult; Area Under Curve; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Female; Hepatocytes; Humans; Inhibitor of Apoptosis Proteins; Male; Microsomes, Liver; Midazolam; Middle Aged; Models, Biological; Pregnane X Receptor; Receptors, Steroid; RNA, Messenger; Thiazoles; Time Factors; Young Adult

2013